SCHEMBL7516192

SCHEMBL7516192

COc1ccc2c(c1)c(-c1cncc(-c3ccc(Cl)cc3)c1)cn2CC(C)CN(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.54
FLT1 P17948 1/20 0.54
FLT4 P35916 1/20 0.54
PDE4B Q07343 2/20 0.40
PDE4D Q08499 1/20 0.40
HTR6 P50406 5/20 0.38
CYP11B1 P15538 4/20 0.37
CYP11B2 P19099 4/20 0.37
CYP17A1 P05093 3/20 0.37
GSK3B P49841 2/20 0.36
QPCT Q16769 2/20 0.36
CYP3A4 P08684 2/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7553739 0.94 KDR (0.54) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7505010 0.94 KDR (0.58) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7977281 0.91 KDR (0.61) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7506521 0.90 KDR (0.60) KDRFLT1FLT4KCNH2
SCHEMBL7504838 0.90 KDR (0.54) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7552655 0.88 KDR (0.54) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7507277 0.88 KDR (0.58) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7976092 0.86 KDR (0.70) KDRFLT1FLT4HTR6CYP11B1
SCHEMBL7976518 0.85 KDR (0.72) KDRFLT1FLT4PDE4BPDE4D
SCHEMBL7550053 0.85 KDR (0.75) KDRFLT1FLT4PDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed